![Stelios Papadopoulos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stelios Papadopoulos
Fondateur chez
EXELIXIS, INC.
Fortune : 61 M $ au 31/05/2026
Profil
Le Dr Stelios Papadopoulos est président du conseil d'administration d'Eucrates Biomedical Acquisition Corp, président du conseil d'administration de Regulus Therapeutics, Inc. et président du conseil d'administration de Biogen, Inc. et président du conseil de surveillance de Biogen GmbH, président et trésorier de la Fondation Sant, président du conseil d'administration d'Exelixis, Inc. et professeur associé à l'université de New York. Il est membre du conseil d'administration de Biogen Idec, Inc. (Caroline du Nord), Diacrin, Inc. (Delaware), du National Marrow Donor Program et de The BioExec Institute, Inc. Le Dr Papadopoulos a été précédemment employé en tant que directeur indépendant par BG Medicine, Inc. et fondateur de Cellzome Ltd, vice-président de Cowen & Co. LLC, de président du conseil d'administration d'Anadys Pharmaceuticals, Inc. et de président d'Instrumentation Laboratory Co., de président du conseil d'administration de PaineWebber Development Corp. et de banquier d'affaires de PaineWebber, Inc. et de président du conseil d'administration de Cellzome, Inc. et de vice-président du département de recherche sur les actions de Drexel Burnham Lambert, Inc. Il a également été membre du conseil d'administration de GenVec, Inc, SGX Pharmaceuticals, Inc, Biogen Idec New Ventures, Inc, Joule Unlimited Technologies, Inc et Neuronyx, Inc. Il a obtenu un diplôme de deuxième cycle de l'université de New York, un MBA de l'université de New York et un doctorat de l'université de New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EXELIXIS, INC. 0,48% | 27/05/2026 | 1 197 595 ( 0,48% ) | 60 M $ | 31/05/2026 |
| 17/04/2026 | 217 578 ( 0,12% ) | 593 988 $ | 31/05/2026 |
Postes actifs de Stelios Papadopoulos
| Sociétés | Poste | Début |
|---|---|---|
| EXELIXIS, INC. | Fondateur | 15/11/1994 |
| OVID THERAPEUTICS INC. | Directeur/Membre du Conseil | 03/03/2025 |
Epikast, Inc.
 Epikast, Inc. Packaged SoftwareTechnology Services Develops AI tools for biopharma and healthcare | Fondateur | - |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The BioExec Institute, Inc.
 The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Directeur/Membre du Conseil | - |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Directeur/Membre du Conseil | - |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Directeur/Membre du Conseil | 01/07/2008 |
National Marrow Donor Program
 National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Provides treatments for those facing life-threatening blood cancers | Directeur/Membre du Conseil | - |
Fondation Santé | Fondateur | 01/01/2000 |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Stelios Papadopoulos
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Stelios Papadopoulos
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
51
Relations au 1er degré
29
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 29 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology Develops bio-pharmaceutical products | Health Technology |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
BG Medicine, Inc.
 BG Medicine, Inc. Medical SpecialtiesHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and manufactures drugs | Health Technology |
Ovid Therapeutics, Inc.
 Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Drexel Burnham Lambert, Inc.
 Drexel Burnham Lambert, Inc. Agricultural Commodities/MillingProcess Industries Manufactures chocolates and sugar candies. | Process Industries |
SGX Pharmaceuticals, Inc.
 SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Instrumentation Laboratory Co.
 Instrumentation Laboratory Co. Medical SpecialtiesHealth Technology Manufactures diagnostic products | Health Technology |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Fondation Santé | |
PaineWebber Development Corp. | |
National Marrow Donor Program
National Marrow Donor Program Miscellaneous Commercial ServicesCommercial Services Provides treatments for those facing life-threatening blood cancers | Commercial Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Joule Unlimited Technologies, Inc.
 Joule Unlimited Technologies, Inc. Industrial SpecialtiesProcess Industries Produces renewable fuels, gases and chemicals | Process Industries |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and supplies pharmaceutical products | Health Technology |
Cellzome, Inc.
 Cellzome, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-inflammation therapy | Health Technology |
The BioExec Institute, Inc.
The BioExec Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as network of executives in the life sciences industry | Commercial Services |
Eucrates Biomedical Acquisition Corp.
 Eucrates Biomedical Acquisition Corp. Financial ConglomeratesFinance Operates as an blank check company | Finance |
Graviton Bioscience Corp.
 Graviton Bioscience Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for the treatment of autoimmune, cancer, genetic, fibrotic and other serious diseases | Health Technology |
Epikast, Inc.
Epikast, Inc. Packaged SoftwareTechnology Services Develops AI tools for biopharma and healthcare | Technology Services |
